I am serial biotech entrepreneur, finding assets locally to develop them globally.
Firstly I co-founded CrystalGenomics after 7 and half years at LG Life Sciences as researcher BD manager. CrystalGenomics, backed by local VCs, went public in 2006 successfully and got an approval of Acelex® (polmacoxib) in Korea. Secondly, Rexbio was founded for the development of mAb against PAUF, which is specifically over-expressed at pancreatic adenocarcinoma.
Specialties: Technology assessment
Formulation of R&D/Business strategy